Supply, Installation, Testing and Commissioning of Dg Set (160 Kva, 3 Phase) for... Tender

Procurement Summary

State: Delhi (NCT)

Summary: Supply, Installation, Testing and Commissioning of Dg Set (160 Kva, 3 Phase) for Covid-19 Management

Deadline: 09 Mar 2023

Other Information

Notice Type: Tender

TOT Ref.No.: 79740566

Document Ref. No.:

Financier: Self Financed

Purchaser Ownership: Public

Document Fees: Refer Document

Tender Value: Refer Document

EMD: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Request for quotation are invited for Supply, Installation, Testing and Commissioning of Dg Set (160 Kva, 3 Phase) for Covid-19 Management Supply, Installation, Testing and Commissioning of DG Set (160 KVA, 3 Phase) for COVID-19 Management I. Summary of Deadlines Release of Request for Quotation 02/03/2023 Confirmation of interest due 06/03/2023 Request for clarifications received by 07/03/2023 Response to Request for clarifications 08/03/2023 Due date and time of bid submission 09/03/2023 up to 24:00 Hrs. Bid Evaluation completed 10/03/2023 Issue of Purchase Order (P.O.) to successful bidder 13/03/2023 Note that CHRI reserves the right to modify this schedule as needed. All prospective bidders who have confirmed interest by the due date as above, will be notified of any changes simultaneously by email. II. CHRI Statement of Business Centre for Health Research and Innovation (CHRI) is a registered company (Not for profit) under section 8 of Companies Act 2013 with Ministry of Corporate Affairs. It is a PATH (An International nonprofit organization) affiliated organization. CHRI is mainly focusing on system and service innovations. It focusses on saving lives and improving health, especially among women and children as India continues to have high maternal, newborn, child mortality, morbidity, and malnutrition. CHRI strategically mobilizes partners in India and take program interventions to scale focusing on verticals such as MNCHN, TB/HIV, Neglected Tropical Diseases and Malaria, and Vaccines. CHRI follows a holistic and health-systems-oriented approach to strengthen the continuum of care across the public health space rather than restricting itself to a specific theme. It can involve advocacy for policies, technologies and resources that improve health services and delivery. III. Purpose of RFQ CHRI is implementing “COVID-19 Respiratory care coordination project” supported by NSE Foundation to improve access to oxygen and supply of other essential equipment in hospitals. NSE Foundation is a Section 8 company that undertakes the CSR activities of the National Stock Exchange of India Limited and its subsidiaries (NSE Group), with a broad vision to enhance the well-being of underprivileged and marginalized communities. In order to implement the project, CHRI has planned to procure Equipment a per Schedule of Requirement below: Schedule No. Brief Description of Equipment Quantity (Nos.) Location of Site/Facility I DG Set (160 KVA, 3 Phase) 1 328 Field Hospital, Nihari, Kupwara, Jammu & Kashmir The detailed Technical Specifications are mentioned in Annexure-A. For detailed information, please check the complete version of the advert attached below

Documents

 Tender Notice